Mutations in the CTNNB1 gene, which encodes β-catenin, are present in approximately 70–80% of hepatoblastoma cases and result in aberrant activation of the Wnt signaling pathway, leading to uncontrolled cell proliferation and tumor development [15]. The gene discussed is CTNNB1; the disease is hepatoblastoma.